Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-CsA Long-term Safety Follow-up in BOS
NCT01439958Phase 3Terminated
- Sponsor
- PARI Pharma
- Start
- Feb 2012
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Cyclosporine Inhalation Solution in Bronchiolitis Obliterans Syndrome (BOS), sponsored by PARI Pharma. Started Feb 2012; status: terminated.
02
Drugs
Cyclosporine Inhalation Solution
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT01439958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01439958.